Drug comparisons
Insulin Regular Human vs Rosiglitazone
Compare regular insulin vs rosiglitazone for type 2 diabetes treatment. Insulin is injectable short-acting, rosiglitazone is oral with CV and HF risks.
No comparison dimensions are available for this page.
Clinical context
This comparison arises for type 2 diabetes patients considering thiazolidinedione therapy versus starting insulin.
Bottom line
Insulin is more versatile and preferred for broader use while rosiglitazone has significant safety limitations.
All medication comparisons